# Corning Incorporated  Share Price Target ‘$38.42’, now -3.6% Downside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-share-price-target-38.42-now-3.6-downside-potential/4121161876
- Published: 2024-06-24T13:40:19+01:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) have now 13 market
analysts covering the stock. The analyst consensus now points to a rating of ‘buy’.
The target price High/Low ranges between $45.00 and $29.00 with the average share
target price sitting at $38.42. (at the time of writing). Given that the stocks 
previous close was at $39.85 this indicates there is a potential downside of -3.6%.
The 50 day MA is $34.91 and the 200 day moving average is $31.55. The market capitalization
for the company is 34.31B. The stock price is currently at: $40.05 USD

 The potential market cap would be $33,076,477,123 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 55.62, revenue per share of $14.57
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on: